Cambridge Cognition Holdings Plc (LON:COG – Get Free Report)’s stock price reached a new 52-week low on Monday . The stock traded as low as GBX 34 ($0.44) and last traded at GBX 34 ($0.44), with a volume of 3723 shares. The stock had previously closed at GBX 35 ($0.46).
Cambridge Cognition Price Performance
The company’s 50-day moving average is GBX 41.16 and its two-hundred day moving average is GBX 44.32. The company has a debt-to-equity ratio of 92.53, a current ratio of 0.65 and a quick ratio of 0.96. The firm has a market cap of £14.05 million, a P/E ratio of -837.50 and a beta of 0.72.
About Cambridge Cognition
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Read More
- Five stocks we like better than Cambridge Cognition
- Dividend Payout Ratio Calculator
- 3 Momentum Trades for October With Ample Upside Ahead
- What is MarketRank™? How to Use it
- Roblox Dips on Short Report—Here’s Why It Could Bounce Back Fast
- Top Biotech Stocks: Exploring Innovation Opportunities
- 2 Reasons to Jump on Apple Stock Now and 1 Reason to Think Twice
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.